SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Fisher Scientific International Inc – ‘10-K’ for 12/31/05 – EX-31.02

On:  Tuesday, 2/21/06, at 4:29pm ET   ·   For:  12/31/05   ·   Accession #:  950135-6-1054   ·   File #:  1-10920

Previous ‘10-K’:  ‘10-K’ on 3/16/05 for 12/31/04   ·   Latest ‘10-K’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/21/06  Fisher Scientific Int’l Inc       10-K       12/31/05   11:1.3M                                   Bowne of Boston/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10-K - Fisher Scientific International, Inc.   HTML   1.08M 
 2: EX-10.33    EX-10.33 - Second Amendment to Credit Agreement       16     56K 
 3: EX-10.37    EX-10.37 - First Amendment to Receivables Transfer    11     34K 
                          Agreement                                              
 4: EX-10.40    EX-10.40 - Waiver and Omnibus                          9     27K 
 5: EX-12.01    EX-12.01 - Computation of Ratios                       1      8K 
 6: EX-21.01    EX-21.01 - List of Subsidiaries of the Registrant      8     35K 
 7: EX-23.01    EX-23.01 Consent of Deloitte & Touche, LLP             1      8K 
 8: EX-31.01    EX-31.01 - SEC 302 Certification of CEO             HTML     12K 
 9: EX-31.02    EX-31.02 - SEC 302 Certification of CFO             HTML     12K 
10: EX-32.01    EX-32.01 - SEC 906 Certification of CEO             HTML      8K 
11: EX-32.02    EX-32.02 - SEC 906 Certification of CFO             HTML      8K 


EX-31.02   —   EX-31.02 – SEC 302 Certification of CFO


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  exv31w02  

 

         
EXHIBIT 31.02
CERTIFICATION
I, Kevin P. Clark, certify that:
1. I have reviewed this annual report on Form 10-K of Fisher Scientific International Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
         
     
Date: February 17, 2006  By:   /s/ Kevin P. Clark    
    Kevin P. Clark   
    Chief Financial Officer
Fisher Scientific International Inc. 
 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/21/064
2/17/064
For Period End:12/31/05
 List all Filings 
Top
Filing Submission 0000950135-06-001054   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 9:39:13.0am ET